Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-07-02

Clinical Trial Update: The Prolonged Use of Topiramate for Preventing Migraine Headaches [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial assessing prolonged use of topiramate to prevent migraine headaches has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topamax (Topiramate)

Snippet

Sponsor: Janssen Pharmaceutica N.V., Belgium | Conditions: Migraine | Phase 3 | Status: COMPLETED